| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.31 | 0.05 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.05 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |